Search
Keyword
Search in sections (Example, from 802)
OR
Volume
Find
Product Classification
Reg.Number
Title 21: Food and Drugs
Subpart A - General Provisions
§ 1002.1 Applicability.

The provisions of this part are applicable as follows:

(a) All manufacturers of electronic products are subject to § 1002.20.

(b) Manufacturers, dealers, and distributors of electronic products are subject to the provisions of part 1002 as set forth in table 1 of this section, unless excluded by paragraph (c) of this section, or unless an exemption has been granted under § 1002.50 or § 1002.51.

(c) The requirements of part 1002 as specified in table 1 of this section are not applicable to:

(1) Manufacturers of electronic products intended solely for export if such product is labeled or tagged to show that the product meets all the applicable requirements of the country to which such product is intended for export.

(2) Manufacturers of electronic products listed in table 1 of this section if such product is sold exclusively to other manufacturers for use as components of electronic products to be sold to purchasers, with the exception that the provisions are applicable to those manufacturers certifying components of diagnostic x-ray systems pursuant to provisions of § 1020.30(c) of this chapter.

(3) Manufacturers of electronic products that are intended for use by the U.S. Government and whose function or design cannot be divulged by the manufacturer for reasons of national security, as evidenced by government security classification.

(4) Assemblers of diagnostic x-ray equipment subject to the provisions of § 1020.30(d) of this chapter, provided the assembler has submitted the report required by § 1020.30(d)(1) or (d)(2) of this chapter and retains a copy of such report for a period of 5 years from its date.

Table 1 - Record and Reporting Requirements By Product

Manufacturer Dealer & Distributor
Products Product reports § 1002.10 Supplemental reports § 1002.11 Abbreviated reports § 1002.12 Annual reports § 1002.13 Test records § 1002.30(a) 1 Distribution records § 1002.30(b) 2 Distribution records §§ 1002.40 and 1002.41
DIAGNOSTIC X-RAY 3 (1020.30, 1020.31, 1020.32, 1020.33)
Computed tomographyXXXXXX
X-ray system 4XXXXXX
Tube housing assemblyXXXXX
X-ray controlXXXXXX
X-ray high voltage generatorXXXXXX
X-ray table or cradleXXXX
X-ray film changerXXX
Vertical cassette holders mounted in a fixed location and cassette holders with front panelsXXXX
Beam-limiting devicesXXXXXX
Spot-film devices and image intensifiers manufactured after April 26, 1977XXXXXX
Cephalometric devices manufactured after February 25, 1978XXX
Image receptor support devices for mammographic X-ray systems manufactured after September 5, 1978XXXX
CABINET X RAY (§ 1020.40)
Baggage inspectionXXXXXX
OtherXXXXX
PRODUCTS INTENDED TO PRODUCE PARTICULATE RADIATION OR X-RAYS OTHER THAN DIAGNOSTIC OR CABINET DIAGNOSTIC X-RAY
MedicalXXXX
AnalyticalXXXX
IndustrialXXXX
TELEVISION PRODUCTS (§ 1020.10)
<25 kilovolt (kV) and <0.1 milliroentgen per hour (mR/hr IRLC 5 6XX 6
≥25kV and <0.1mR/hr IRLC 5XXX
≥0.1mR/hr IRLC 5XXXXX
MICROWAVE/RF
MW ovens (§ 1030.10)XXXXX
MW diathermyX
MW heating, drying, security systemsX
RF sealers, electromagnetic induction and heating equipment, dielectric heaters (2-500 megahertz)X
OPTICAL
Phototherapy productsXX
Laser products (§§ 1040.10, 1040.11)
Class I lasers and products containing such lasers 7XXX
Class I laser products containing class IIa, II, IIIa, lasers 7XXXX
Class IIa, II, IIIa lasers and products other than class I products containing such lasers 7XXXXXX
Class IIIb and IV lasers and products containing such lasers 7XXXXXX
Sunlamp products (§ 1040.20)
Lamps onlyX
Sunlamp productsXXXXXX
Mercury vapor lamps (§ 1040.30)
T lampsXXX
R lampsX
ACOUSTIC
Ultrasonic therapy (1050.10)XXXXXX
Diagnostic ultrasoundX
Medical ultrasound other than therapy or diagnosticXX
Nonmedical ultrasoundX

1However, authority to inspect all appropriate documents supporting the adequacy of a manufacturer's compliance testing program is retained.

2The requirement includes §§ 1002.31 and 1002.42, if applicable.

3Report of Assembly (Form FDA 2579) is required for diagnostic x-ray components; see 21 CFR 1020.30(d)(1) through (d)(3).

4Systems records and reports are required if a manufacturer exercises the option and certifies the system as permitted in 21 CFR 1020.30(c).

5Determined using the isoexposure rate limit curve (IRLC) under phase III test conditions (1020.10(c)(3)(iii)).

6Annual report is for production status information only.

7Determination of the applicable reporting category for a laser product shall be based on the worst-case hazard present within the laser product.

[60 FR 48382, Sept. 19, 1995; 61 FR 13423, Mar. 27, 1996]
§ 1002.2 [Reserved]
§ 1002.3 Notification to user of performance and technical data.

The Director and Deputy Director of the Center for Devices and Radiological Health, as authorized under delegated authority, may require a manufacturer of a radiation emitting electronic product to provide to the ultimate purchaser, at the time of original purchase, such performance data and other technical data related to safety of the product as the Director or Deputy Director finds necessary.

[69 FR 17292, Apr. 2, 2004]
§ 1002.4 Confidentiality of information.

The Secretary or his representative shall not disclose any information reported to or otherwise obtained by him, pursuant to this part, which concerns or relates to a trade secret or other matter referred to in section 1905 of title 18 of the United States Code, except that such information may be disclosed to other officers or employees of the Department and of the other agencies concerned with carrying out the requirements of the Act. Nothing in this section shall authorize the withholding of information by the Secretary, or by any officers or employees under his control, from the duly authorized committees of the Congress.

§ 1002.7 Submission of data and reports.

All submissions such as reports, test data, product descriptions, and other information required by this part, or voluntarily submitted to the Director, Center for Devices and Radiological Health, shall be filed with the number of copies as prescribed by the Director, Center for Devices and Radiological Health, and shall be signed by the person making the submission. The submissions required by this part shall be addressed to the Food and Drug Administration, Center for Devices and Radiological Health, ATTN: Electronic Product Reports, Document Mail Center, 10903 New Hampshire Ave., Bldg. 66, rm. G609, Silver Spring, MD 20993-0002.

(a) In addition to the requirements of this part, all material submitted to the Director, Center for Devices and Radiological Health, shall be submitted pursuant to the provisions of part 20 - Public Information, of this chapter.

(b) Where guides or instructions have been issued by the Director for the submission of material required by this part, such as test data, product reports, abbreviated reports, supplemental reports, and annual reports, the material submitted shall conform to the applicable reporting guides or instructions. Where it is not feasible or where it would not be appropriate to conform to any portion of a prescribed reporting guide or instruction, an alternate format for providing the information requested by that portion of the guide or instruction may be used provided the submitter of such information submits adequate explanation and justification for use of an alternate format. If the Director, Center for Devices and Radiological Health, determines that such justification is inadequate and that it is feasible or appropriate to conform to the prescribed reporting guide or instruction, he may require resubmission of the information in conformance with the reporting guide or instruction.

(c) Where the submission of quality control and testing information is common to more than one model, or model family of the same product category, a “common aspects report” consolidating similar information may be provided, if applicable.

[42 FR 18062, Apr. 5, 1977, as amended at 53 FR 11254, Apr. 6, 1988; 60 FR 48385, Sept. 19, 1995; 72 FR 17400, Apr. 9, 2007; 75 FR 20916, Apr. 22, 2010]
Skip to content